254 related articles for article (PubMed ID: 9531272)
1. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon DY; Dinarello CA
J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
[TBL] [Abstract][Full Text] [Related]
2. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
4. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling.
Korherr C; Hofmeister R; Wesche H; Falk W
Eur J Immunol; 1997 Jan; 27(1):262-7. PubMed ID: 9022028
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.
Zetterström M; Lundkvist J; Malinowsky D; Eriksson G; Bartfai T
Eur Cytokine Netw; 1998 Jun; 9(2):131-8. PubMed ID: 9681388
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
[TBL] [Abstract][Full Text] [Related]
7. Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha.
Netea MG; Kullberg BJ; Boerman OC; Verschueren I; Dinarello CA; Van der Meer JW
J Immunol; 1999 Apr; 162(8):4876-81. PubMed ID: 10202032
[TBL] [Abstract][Full Text] [Related]
8. IL-1 receptor accessory protein is an essential component of the IL-1 receptor.
Cullinan EB; Kwee L; Nunes P; Shuster DJ; Ju G; McIntyre KW; Chizzonite RA; Labow MA
J Immunol; 1998 Nov; 161(10):5614-20. PubMed ID: 9820540
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of anti-IL-1R accessory protein antibodies on IL-1alpha or IL-1beta-induced production of PGE(2) and IL-6 from 3T3-L1 cells.
Yoon DY; Dinarello CA
J Biochem Mol Biol; 2007 Jul; 40(4):562-70. PubMed ID: 17669273
[TBL] [Abstract][Full Text] [Related]
10. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
Clark BD; Ikejima T; Mancilla J; Orencole SF; Sirko SP; Ishii N; Okuda K; Dinarello CA
J Interferon Cytokine Res; 1996 Dec; 16(12):1079-88. PubMed ID: 8974012
[TBL] [Abstract][Full Text] [Related]
11. A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.
Lu HL; Yang CY; Chen HC; Hung CS; Chiang YC; Ting LP
Mol Immunol; 2008 Mar; 45(5):1374-84. PubMed ID: 17949817
[TBL] [Abstract][Full Text] [Related]
12. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein.
Jensen LE; Muzio M; Mantovani A; Whitehead AS
J Immunol; 2000 May; 164(10):5277-86. PubMed ID: 10799889
[TBL] [Abstract][Full Text] [Related]
13. Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance.
D'Ettorre C; De Chiara G; Casadei R; Boraschi D; Tagliabue A
Eur Cytokine Netw; 1997 Jun; 8(2):161-71. PubMed ID: 9262965
[TBL] [Abstract][Full Text] [Related]
14. Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity.
McKean DJ; Podzorski RP; Bell MP; Nilson AE; Huntoon CJ; Slack J; Dower SK; Sims J
J Immunol; 1993 Oct; 151(7):3500-10. PubMed ID: 8376789
[TBL] [Abstract][Full Text] [Related]
15. IL-1 and IL-4 modulate IL-1 receptor expression in a murine T cell line.
Lacey DL; Erdmann JM
J Immunol; 1990 Dec; 145(12):4145-53. PubMed ID: 2147936
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase is essential for the constitutive expression of type I interleukin-1 receptor in human fibroblast cells.
Takii T; Ito A; Kawashima S; Ninomiya A; Matsumura T; Hayashi H; Onozaki K
Eur Cytokine Netw; 1999 Jun; 10(2):237-46. PubMed ID: 10400830
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of type I IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes.
Ito A; Takii T; Matsumura T; Onozaki K
J Immunol; 1999 Apr; 162(7):4260-5. PubMed ID: 10201956
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta down-regulates IL-1alpha-induced TLR2 expression in murine hepatocytes.
Matsumura T; Hayashi H; Takii T; Thorn CF; Whitehead AS; Inoue J; Onozaki K
J Leukoc Biol; 2004 Jun; 75(6):1056-61. PubMed ID: 15039464
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of the interleukin-1 receptor type I is required for optimal binding of interleukin-1.
Mancilla J; Ikejima T; Dinarello CA
Lymphokine Cytokine Res; 1992 Aug; 11(4):197-205. PubMed ID: 1420598
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor.
Malinowsky D; Lundkvist J; Layé S; Bartfai T
FEBS Lett; 1998 Jun; 429(3):299-302. PubMed ID: 9662436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
